Literature DB >> 20018511

A novel mitochondrial MTND5 frameshift mutation causing isolated complex I deficiency, renal failure and myopathy.

Charlotte L Alston1, Monika Morak, Christopher Reid, Iain P Hargreaves, Simon A S Pope, John M Land, Simon J Heales, Rita Horvath, Helen Mundy, Robert W Taylor.   

Abstract

Isolated complex I deficiency is the most commonly reported enzyme defect in paediatric mitochondrial disorders, and may arise due to mutations in nuclear-encoded structural or assembly genes, or the mitochondrial genome. We present the clinical, biochemical and molecular genetic data in a young girl whose clinical picture is dominated by chronic renal failure, myopathy and persistent lactic acidosis. An isolated complex I deficiency in muscle was identified due to a novel mutation (m.12425delA) in the MTND5 gene. This single nucleotide deletion is heteroplasmic and detectable in several tissues from the proband but not her mother, suggesting a de novo mutation event. The description of the first frameshift mutation in a mitochondrial complex I gene affirms mitochondrial DNA mutations as an important cause of isolated complex I deficiency in children and the importance of whole mitochondrial genome sequencing in the diagnostic work-up to elucidate the underlying molecular genetic abnormality and provide important genetic advice. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018511     DOI: 10.1016/j.nmd.2009.10.010

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  18 in total

1.  Mitochondrial tRNA(Phe) mutation as a cause of end-stage renal disease in childhood.

Authors:  Kristin E D'Aco; Megan Manno; Colleen Clarke; Jaya Ganesh; Kevin E C Meyers; Neal Sondheimer
Journal:  Pediatr Nephrol       Date:  2012-11-08       Impact factor: 3.714

2.  Comparison of mitochondrial mutation spectra in ageing human colonic epithelium and disease: absence of evidence for purifying selection in somatic mitochondrial DNA point mutations.

Authors:  Laura C Greaves; Joanna L Elson; Marco Nooteboom; John P Grady; Geoffrey A Taylor; Robert W Taylor; John C Mathers; Thomas B L Kirkwood; Doug M Turnbull
Journal:  PLoS Genet       Date:  2012-11-15       Impact factor: 5.917

3.  Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA.

Authors:  Alexander N Gorelick; Minsoo Kim; Walid K Chatila; Konnor La; A Ari Hakimi; Michael F Berger; Barry S Taylor; Payam A Gammage; Ed Reznik
Journal:  Nat Metab       Date:  2021-04-08

4.  Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes.

Authors:  E J Swan; R M Salem; N Sandholm; L Tarnow; P Rossing; M Lajer; P H Groop; A P Maxwell; A J McKnight
Journal:  Diabet Med       Date:  2015-04-13       Impact factor: 4.359

5.  A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid Cancer.

Authors:  Xingyun Su; Weibin Wang; Guodong Ruan; Min Liang; Jing Zheng; Ye Chen; Huiling Wu; Thomas J Fahey; Minxin Guan; Lisong Teng
Journal:  Int J Mol Sci       Date:  2016-10-10       Impact factor: 5.923

6.  Focal segmental glomerulosclerosis associated with mitochondrial disease.

Authors:  Kenneth Lim; David Steele; Andrew Fenves; Ravi Thadhani; Eliot Heher; Amel Karaa
Journal:  Clin Nephrol Case Stud       Date:  2017-03-03

7.  Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease.

Authors:  Ken Ishii; Hanako Kobayashi; Kensei Taguchi; Nan Guan; Andraia Li; Carmen Tong; Olena Davidoff; Pamela V Tran; Madhulika Sharma; Navdeep S Chandel; Meghan E Kapp; Agnes B Fogo; Craig R Brooks; Volker H Haase
Journal:  Kidney Int       Date:  2020-11-04       Impact factor: 10.612

Review 8.  Renal manifestations of genetic mitochondrial disease.

Authors:  John F O'Toole
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-01-31

9.  Next-generation sequencing of the mitochondrial genome and association with IgA nephropathy in a renal transplant population.

Authors:  Adam P Douglas; Dwaine R Vance; Elaine M Kenny; Derek W Morris; Alexander P Maxwell; Amy Jayne McKnight
Journal:  Sci Rep       Date:  2014-12-09       Impact factor: 4.379

10.  De novo mtDNA point mutations are common and have a low recurrence risk.

Authors:  Suzanne C E H Sallevelt; Christine E M de Die-Smulders; Alexandra T M Hendrickx; Debby M E I Hellebrekers; Irenaeus F M de Coo; Charlotte L Alston; Charlotte Knowles; Robert W Taylor; Robert McFarland; Hubert J M Smeets
Journal:  J Med Genet       Date:  2016-07-22       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.